Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck's pharma unit faces tougher 2017 as fertility boost recedes

Merck's pharma unit faces tougher 2017 as fertility boost recedes A run of buoyant growth for Merck KGaA's fertility portfolio - driven by the withdrawal from the market of competitor products - is less likely to continue through 2017, according to the ... Last year, Merck abandoned plans to seek approval of

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running The Access to Medicines ranking largely reflects this trend as GSK, Johnson &Johnson, Merck KGaA and Merck &Co take the top five places, joined by AstraZeneca, which climbed eight places to

Deal Watch October 2016

Deal Watch October 2016 For example Samsung Bioepis also based in South Korea, signed a deal with Merck &Co in 2013 for a range of biosimilars including infliximab, trastuzumab and etanercept (Amgen's Enbrel with ... $730m ($50m). Apitope (UK) / Jan 09. Merck KGaA (DE).

NICE set to reject Merck’s Erbitux for head and neck cancer

NICE set to reject Merck’s Erbitux for head and neck cancer NICE is poised not to back Merck KGaA's Erbitux (cetuximab) for the treatment of recurrent and/or metastatic squamous cell cancer of the head and neck on the NHS. ... Merck has since provided further evidence for Erbitux to assist this appraisal process,

Merck licenses University of Edinburgh research tool

Merck licenses University of Edinburgh research tool Gains access to novel disease progression technology. Merck KGaA has acquired access to a pioneering research tool from The University of Edinburgh for the study of early stage disease progression. ... Merck's Udit Batra, chief executive of Merck Life

[ Previous 5 results ] 22 23 24 25 26 27 28 29 30 31 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Redbow Consulting Group

Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...

Latest intelligence

Personalised medicine: driving a need for greater diversity in clinical trials
Kate Shaw, Innovative Trials' Founder & CEO, investigates one of the biggest challenges facing clinical research today....
Congresses and conferences
Superstar congresses and conferences will stay centre stage but now share the limelight with virtual and hybrid events
With the pandemic having dimmed the lights on pharma conferences, their virtual and hybrid replacements have grasped the opportunity and are here to stay...
Cervical Cancer Prevention Month
In this first 2022 blog, the Innovative Trials' Equality & Diversity committee will be looking at raising awareness around Cervical Cancer...